Science & tech

Science & tech

Optimising market access for rare disease products: insights from Craig Caceci

By Rebecca Pender

27 February 2023

Science & tech

The real-world evidence revolution: how better research can improve patients’ lives

By Rebecca Pender

27 October 2022

Science & tech

Merging the metaverse and the rare disease community: join the conversation

By Rebecca Pender

22 September 2022

Science & tech

Sure, you’ve heard about GNEM. But do you know about the Bulgarian variant?

By Rebecca Pender

19 May 2022

Science & tech

The transition to precision medicine “one size fits all” to “my medicine”

By Rebecca Pender

13 January 2021

Science & tech

Introducing our newest RARE Revolution columnist for our new #RARETech column

By Rebecca Pender

11 January 2021

Science & tech

PTC Therapeutics highlights data on high disease burden and value of treatment across two rare diseases

By Rebecca Pender

24 November 2020